CCCC SCHEDULE 13G/A: SEC filing

RA Capital Management and affiliated entities

Filed with the SEC on · accession 0001346824-26-000277

CCCC filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -4.0% by the first close after the filing.

Summary of the filing

RA Capital Management and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of 9.99% of C4 Therapeutics common stock as of September 30, 2026, including shares and warrants subject to beneficial ownership blockers.

Key details

Shares of common stock beneficially owned$13.7M
Shares of common stock directly held by the Fund$8.2M
Class A warrants exercisable for shares$16.2M
Class B warrants exercisable for shares$16.2M
Reporting person / investment adviserRA Capital Management, L.P.
Direct holder of securitiesRA Capital Healthcare Fund, L.P.
IssuerC4 Therapeutics, Inc.
Manager, ra capital managementPeter Kolchinsky
Manager, ra capital managementRajeev Shah

How CCCC stock reacted

Close before

$2.76

Nov 13, 2026

First close after

-3.99%

$2.65

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for CCCC, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CCCC?

Click here

Frequently asked questions

What did CCCC file with the SEC on Nov 16, 2026?

CCCC filed a SCHEDULE 13G/A (SEC filing). RA Capital Management and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of 9.99% of C4 Therapeutics common stock as of September 30, 2026, including shares and warrants subject to beneficial ownership blockers.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did CCCC stock react to this filing?

CCCC closed at $2.76 before the filing and $2.65 on Nov 16, 2026 (-3.99%).

Other CCCC SEC filings

Get alerts when CCCC files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days